ArticleBiochimica et biophysica acta2012

Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors.

Li-Hua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.